3 years ago

TestCard Secures USD10 Million to Expand MedTech Platform

  • TestCard, a UK-based MedTech company, has raised USD10 million in funding from West Hill Capital

  • The company intends to use the funds to commercialize its existing product suite, launch new products, and invest in its technology

  • TestCard's platform turns smartphones into clinical-grade scanners for rapid diagnostic medical tests, making testing more accessible for consumers and transforming workflows in clinical settings

  • The company has secured retail partnerships for its UTI test and treat service and launched its Covid-19 antigen testing solution, ClearScreen, into the NHS

  • TestCard is looking to launch in the US in early 2023.

      • ProblemHealthcare

      "Making diagnostic testing more accessible and affordable, especially in the UK's already strained healthcare system"

      Solution

      "Leveraging smartphone technology to turn them into clinical-grade scanners, allowing accurate interpretation of rapid diagnostic tests. This helps streamline workflows in clinical settings and makes testing more accessible for consumers."

      Covered on